As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: March 1, 2012
by Mark Hollmer for Fierce Biotech Research
Even as researchers become increasingly concerned about finding a drug that can manage or defeat Alzheimer’s disease, scientists at Canada’s Simon Fraser University bet the answer comes down to sugar.
Rather than reaching for high-sugar foods to protect your brain, however, their discovery here is more elemental.
Keep sugar levels stable in the brain protein tau, the scientists believe, and the action could slow Alzheimer’s progression, or even prevent the disease from happening. What’s more, they’ve come up with a chemical inhibitor that might prevent depletion of those vital sugar molecules.
Consider that we’re years away from seeing if researchers can repeat these promising results in larger animal trials and then in people. Mouse trials can be encouraging but are not always repeatable in humans for all kinds of genetic reasons. At the same time, with all the increasing U.S. and global focus on developing a viable Alzheimer’s treatment, the finding remains interesting because it offers a new targeting approach.
Simon Fraser chemistry professor David Vocadlo and 6 other researchers build on earlier research that found tau in brains of patients with Alzheimer’s with virtually no sugar attached, and that the naturally occurring O-GlcNAcase enzyme drained the supply.
The tau clumps are important because they offer an Alzheimer’s warning sign and worsen as the disease does, the researchers explain. And so, Vocadlo’s team created a chemical compound called Thiamet-G and tested it in mice, having them drink it daily in water. They found that mice drinking the special concoction blocked the enzyme from taking vital tau sugar away, developed less tau clumps than their brethren who didn’t ingest the compound, and kept their brains in healthier shape.
For the first time, scientists have produced evidence in living humans that the protein tau, which mars the brain in Alzheimer’s disease, spreads from neuron to neuron. Although such movement wasn’t directly observed, the finding...
When the average person goes to the doctor, shows up at the ER, or enters the hospital, the possibility of controlling what happens next is minimal. We put ourselves...
According to the Alzheimer’s Society of Canada, 72% of Canadians living with Alzheimer’s disease are women. Is that because of their biological sex at birth? Does it have to do with the fact that...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.